Literature DB >> 23161608

Transcription factors link mouse WAP-T mammary tumors with human breast cancer.

Benjamin Otto1, Thomas Streichert, Florian Wegwitz, Heidrun Gevensleben, Kristin Klätschke, Christoph Wagener, Wolfgang Deppert, Genrich V Tolstonog.   

Abstract

Mouse models are important tools to decipher the molecular mechanisms of mammary carcinogenesis and to mimic the respective human disease. Despite sharing common phenotypic and genetic features, the proper translation of murine models to human breast cancer remains a challenging task. In a previous study we showed that in the SV40 transgenic WAP-T mice an active Met-pathway and epithelial-mesenchymal characteristics distinguish low- and high-grade mammary carcinoma. To assign these murine tumors to corresponding human tumors we here incorporated the analysis of expression of transcription factor (TF) coding genes and show that thereby a more accurate interspecies translation can be achieved. We describe a novel cross-species translation procedure and demonstrate that expression of unsupervised selected TFs, such as ELF5, HOXA5 and TFCP2L1, can clearly distinguish between the human molecular breast cancer subtypes--or as, for example, expression of TFAP2B between yet unclassified subgroups. By integrating different levels of information like histology, gene set enrichment, expression of differentiation markers and TFs we conclude that tumors in WAP-T mice exhibit similarities to both, human basal-like and non-basal-like subtypes. We furthermore suggest that the low- and high-grade WAP-T tumor phenotypes might arise from distinct cells of tumor origin. Our results underscore the importance of TFs as common cross-species denominators in the regulatory networks underlying mammary carcinogenesis.
Copyright © 2012 UICC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23161608     DOI: 10.1002/ijc.27941

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  Fatty acid oxidation is required for embryonic stem cell survival during metabolic stress.

Authors:  Hualong Yan; Navdeep Malik; Young-Im Kim; Yunlong He; Mangmang Li; Wendy Dubois; Huaitian Liu; Tyler J Peat; Joe T Nguyen; Yu-Chou Tseng; Gamze Ayaz; Waseem Alzamzami; King Chan; Thorkell Andresson; Lino Tessarollo; Beverly A Mock; Maxwell P Lee; Jing Huang
Journal:  EMBO Rep       Date:  2021-05-05       Impact factor: 9.071

2.  Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells.

Authors:  Claudia Maenz; Eva Lenfert; Klaus Pantel; Udo Schumacher; Wolfgang Deppert; Florian Wegwitz
Journal:  BMC Cancer       Date:  2015-03-26       Impact factor: 4.430

3.  An inducible transgenic mouse breast cancer model for the analysis of tumor antigen specific CD8+ T-cell responses.

Authors:  Michael Bruns; Jara Wanger; Olaf Utermöhlen; Wolfgang Deppert
Journal:  Oncotarget       Date:  2015-11-17

4.  Cancer immunotherapy: weak beats strong.

Authors:  Wolfgang Deppert; Michael Bruns
Journal:  Aging (Albany NY)       Date:  2016-11-30       Impact factor: 5.682

5.  A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target.

Authors:  Prashant K Srivastava; Jonathan van Eyll; Patrice Godard; Manuela Mazzuferi; Andree Delahaye-Duriez; Juliette Van Steenwinckel; Pierre Gressens; Benedicte Danis; Catherine Vandenplas; Patrik Foerch; Karine Leclercq; Georges Mairet-Coello; Alvaro Cardenas; Frederic Vanclef; Liisi Laaniste; Isabelle Niespodziany; James Keaney; Julien Gasser; Gaelle Gillet; Kirill Shkura; Seon-Ah Chong; Jacques Behmoaras; Irena Kadiu; Enrico Petretto; Rafal M Kaminski; Michael R Johnson
Journal:  Nat Commun       Date:  2018-09-03       Impact factor: 14.919

6.  Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis.

Authors:  Jinbeom Heo; Byeong-Joo Noh; Seungun Lee; Hye-Yeon Lee; YongHwan Kim; Jisun Lim; Hyein Ju; Hwan Yeul Yu; Chae-Min Ryu; Peter Cw Lee; Hwangkyo Jeong; Yumi Oh; Kyunggon Kim; Sang-Yeob Kim; Jaekyoung Son; Bumsik Hong; Jong Soo Kim; Yong Mee Cho; Dong-Myung Shin
Journal:  EMBO Mol Med       Date:  2019-11-11       Impact factor: 12.137

7.  Aberrant Proliferation of Differentiating Alveolar Cells Induces Hyperplasia in Resting Mammary Glands of SV40-TAg Transgenic Mice.

Authors:  Timo Quante; Florian Wegwitz; Julia Abe; Alessandra Rossi; Wolfgang Deppert; Wolfgang Bohn
Journal:  Front Oncol       Date:  2014-06-26       Impact factor: 6.244

8.  T-cell epitope strength in WAP-T mouse mammary carcinomas is an important determinant in PD1/PD-L1 immune checkpoint blockade therapy.

Authors:  Michael Bruns; Jara Wanger; Udo Schumacher; Wolfgang Deppert
Journal:  Oncotarget       Date:  2016-10-04

9.  CEACAM1 controls the EMT switch in murine mammary carcinoma in vitro and in vivo.

Authors:  Florian Wegwitz; Eva Lenfert; Daniela Gerstel; Lena von Ehrenstein; Julia Einhoff; Geske Schmidt; Matthew Logsdon; Johanna Brandner; Gisa Tiegs; Nicole Beauchemin; Christoph Wagener; Wolfgang Deppert; Andrea Kristina Horst
Journal:  Oncotarget       Date:  2016-09-27

10.  Chromosome 2q gain and epigenetic silencing of GATA3 in microglandular adenosis of the breast.

Authors:  Martin Radner; Jana Lisa van Luttikhuizen; Stephan Bartels; Janin Bublitz; Isabel Grote; Luisa Rieger; Henriette Christgen; Helge Stark; Christopher Werlein; Marcel Lafos; Doris Steinemann; Ulrich Lehmann; Matthias Christgen; Hans Kreipe
Journal:  J Pathol Clin Res       Date:  2020-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.